Navigation Links
PRA International Hosts a Late Phase Services Webinar Establishing Value for Diagnostics & Biomarkers in a Real-Life Setting
Date:2/17/2010

RALEIGH, N.C., Feb. 17 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, will host a webinar on establishing value for diagnostics and biomarkers in a real-life setting on 23 February 2010 at 11:30 a.m. (EST). Two of PRA's Late Phase Services experts — Senior Scientific Affairs Director Jerome Wilson, MA, Ph.D., and Scientific Affairs Director Kathleen Kushner, MPH, RN — will be the presenters.

Dr. Wilson and Ms. Kushner will discuss how biomarkers and diagnostics can enable the medical community to more accurately diagnose and treat human conditions while containing medical costs. The webinar will also review the forthcoming evidence-driven environment and its demand for more clinical applications for diagnostic biomarker testing, personalized medicine and the challenges unique to the operational execution of biomarker and diagnostic research.

PRA's Late Phase Services unit (LPS) provides comprehensive planning and services for all varieties of interventional and non-interventional post-marketing studies on a global scale.  PRA's staff of experts posses an in-depth, current understanding of evolving regional and local non-interventional requirements. Since 2007, PRA has worked on more than 160 late phase studies with up to 17,850 sites and 187,087 patients across 42 countries.

As PRA's Lead Epidemiologist, Dr. Wilson provides consulting services and develops post-marketing strategies for marketed products. Ms. Kushner has managed several post-marketing safety surveillance programs and has focused her professional research career almost exclusively on the area of late phase development.

For more information, navigate to www.praintl.com and click on "Events".  To register for the webinar, email endpoints@praintl.com. The registration deadline is Monday, 22 February 2010.

About PRA International

PRA International conducts clinical trials in more than 75 countries across 6 continents and provides services through all phases of clinical development. PRA performs studies in all therapeutic areas, with specialization in Oncology, Neurosciences, Respiratory/Allergy, Cardiovascular and Infectious Diseases. PRA has supported over 2,100 clinical trials through its 36 global offices.

PRA's therapeutic expertise, global reach and project experience, combined with extensive local knowledge and our differentiating PERSONAL ELEMENT enable our project teams to deliver consistent and on time performance for our clients. This unique PRA philosophy - THE PERSONAL ELEMENT - recognizes that true client service comes only from trained, empowered and dedicated employees who are encouraged to use innovation and their personal commitment to accelerate the development lifecycle.

To learn more about PRA International, please visit www.PRAinternational.com, email Endpoints@PRAintl.com or call our Global Headquarters at +1 (919) 786-8200.

SOURCE PRA International

RELATED LINKS
http://www.prainternational.com
http://www.praintl.com

'/>"/>

SOURCE PRA International
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
2. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
3. Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale dUrologie
4. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
5. International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
6. Surface Logix Presents Positive Phase 1 Repeat-Dose Trial Data on SLx-4090 at The 16th International Symposium on Drugs Affecting Lipid Metabolism
7. Preclinical Data on Lead MEK Inhibitor, RDEA119, to be Presented at the 2007 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
8. Tumor Growth Inhibition and Pharmacokinetic Profile of NKTR-102 (PEG-Irinotecan) in Multiple Solid Tumors To Be Presented at Upcoming AACR-NCI-EORTC International Conference
9. Preimplantation Genetic Diagnosis International Society Refutes American Society of Reproductive Medicine Opinion - States Preimplantation Genetic Screening is Beneficial When Performed in Experienced Centers
10. Survival Data for Avicenas Amyotrophic Lateral Sclerosis Drug Candidate, AL-02, to be Presented at 18th International Symposium on ALS/MND
11. CEL-SCI CEO to Present at the International Society for Pharmaceutical Engineering 2007 Chesapeake BioShowcase
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... 2017 According to a new ... Imaging Digital, Analog), MRI (Closed, Open), Ultrasound, CT, Nuclear ... End User (Hospitals, Imaging Centers) - Global Forecast to ... market over the forecast period of 2016 to 2021. ... by 2021, at a CAGR of 6.6% from 2016 ...
(Date:2/23/2017)... , February 23, 2017 The ... the United States . According to the ... cannabis industry is expected to create 283,422 jobs by 2020, ... compounded over the next four years. The accelerating pace of ... the growth of legal cannabis market, which will further create ...
(Date:2/23/2017)... Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing ... market advanced products and therapies for the Wound Care, ... of healthcare, today announced its record results for the ... Full Year 2016 Highlights are: ... year 2015 revenue Revenue ...
Breaking Medicine Technology:
(Date:2/24/2017)... ... February 24, 2017 , ... ... the Senior International Elite division on February 12th. Ms. Esparza qualified into ... the elite qualifier competition held in Las Vegas, Nevada. Frida is one of ...
(Date:2/23/2017)... Boston, MA (PRWEB) , ... February 23, 2017 ... ... Education and Department of Justice jointly issued a letter to withdraw ... in accordance with their gender identity. The guidance issued in May 2016 by ...
(Date:2/23/2017)... NJ (PRWEB) , ... February 23, 2017 , ... ... media outlet with a clinician-based audience, will be participating in Rare Disease Day ... in Washington, D.C. In addition, Rare Disease Report, a website, weekly e-newsletter and ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... Hamlin Dental ... announce that they are sponsoring a raffle. Throughout the month of February, patients who ... receive a gift card for a dinner for two at the Cheesecake Factory. ...
(Date:2/23/2017)... ... February 23, 2017 , ... On April 13, 2017, ... on “Doping in Sport: How the Culture Might Change,” in conjunction ... The symposium will be held at Pepperdine University in Malibu, California. , Sir ...
Breaking Medicine News(10 mins):